In 2013, the pharmaceutical firm Darnitsa in partnership with Strategic developed a development strategy, which allowed it to achieve the EBITDA targets one year later and the third position in the pharmaceutical market. To maintain its leadership positions and to achieve new ambitious goals, the company’s management and strategic experts Oksana Shchegelska and Roman Burko developed a product portfolio management strategy, a plan to launch changes until 2020 and an action plan for 2018.